Page 7 - Sohini Das

Debt restructuring to reduce interest costs by ₹300 cr by FY27: Biocon CEO

CEO Shreehas Tambe says debt reduction, US state tie-ups, and five fresh product launches will strengthen Biocon Biologics' global biosimilar play

EV charging network Bolt.Earth eyes profitability next year; IPO to follow

CEO of India's largest EV charging network says it would be first such firm to turn profitable; expects revenue to grow fourfold in FY27

Medikabazaar targets 40% annual growth as turnaround gains traction

After reporting an 80% revenue jump and EBITDA positivity in Q2FY26, Medikabazaar plans 40% annual growth over the next three years, even as it navigates a high-profile boardroom dispute

Zydus Lifesciences marks China entry with approval for antidepressant drug

Indian pharma firms start get an opening in China; Glenmark got approval for nasal spray earlier

VinFast slightly outsells Tesla in close fight during festival season

Vinfast sold 137 cars versus Tesla's 109 during the festive months of September and October, as BYD maintained a strong lead with over 1,100 cars sold, according to Fada data

Bajaj Auto posts highest ever quarterly revenue and PAT in Q2FY26

Around 20% of domestic revenues now come from electric vehicle business

Exponent Energy targets 2-2.5 million 3Ws with 24-hour EV retrofit

Backed by Hero MotoCorp's Pawan Munjal, Bengaluru-based Exponent Energy's 'Oto' technology can convert ICE three-wheelers to EVs in 24 hours, targeting 2-2.5 million conversions nationwide

Lupin Q2 PAT rises 73% on strong growth across key global markets

Lupin's consolidated profit rose 73% YoY to Rs 1,478 crore in Q2 FY26, led by robust sales in India and the US and higher margins from an improved product mix

Zydus PAT up 38% on strong India, US growth; board okays ₹5K cr fundraise

Zydus Lifesciences reported a 17% YoY rise in revenue to Rs 6,123 crore and a 38% jump in profit to Rs 1,258.6 crore in Q2 FY26, driven by India and US formulations performance

Sun Pharma Q2 net profit rises 2.5% to ₹3,118 crore on India, EM growth

Sun Pharma's Q2FY26 profit rose to Rs 3,118 crore as India, emerging markets, and rest of world drove growth; US revenues fell 4.1% despite strong gains in innovative medicines

M&M to sell entire 3.45% stake in RBL Bank via ₹682-cr block deal

The automaker's full exit from RBL Bank via a Rs 682 crore block deal brings a 64 per cent return on its year-old investment

M&M Q2 results: Profit rises 16% on strong auto and farm showing

The company reported consolidated PAT of ₹3,673 crore and 22% revenue growth in Q2 FY26, led by robust SUV sales, record tractor volumes, and higher margins across segments

'Bumper' October as two-wheeler retail sales top 2.8 million units

Hero MotoCorp nears 1 million retail sales, Bajaj tops EV chart as strong rural demand and GST boost lift festive momentum

GST 2.0 drives two-wheeler owners to car showrooms, boosts Maruti

GST 2.0 price cuts are bringing a new set of first-time car buyers into Maruti showrooms, with small car bookings rising sharply and a focused campaign launched to ease financing

October car retail outpaces OEM dispatches to dealers, aided by GST reforms

Retail sales, however, outpaced wholesales as vehicles continued to move swiftly out of showrooms

USFDA's new biosimilar norms to woo more players, fast-track mkt entry

Indian cos like Biocon, DRL, Intas, Lupin stand to benefit from the proposed move

Achin Gupta to succeed Umang Vohra as Cipla MD & GCEO from April 2026

Umang Vohra joined Cipla in 2015 as global chief financial and strategy officer and thereafter served as the company's MD & GCEO since 2016

Results preview: Pharma sales may be up 9-10% in Q2 on robust domestic biz

Domestic business and exports are expected to be a shot in the arm; hospitals and diagnostics to lag

This is the start of Hyundai India's next phase of growth: Tarun Garg

Hyundai veteran Tarun Garg will succeed Unsoo Kim as MD & CEO from Jan 1, 2026, marking a new chapter in the automaker's India journey

Q2 results preview: Robust volumes likely drove auto sector growth

But margins may have lost traction due to higher discounts, ad spends